Appropriate antibiotic use and why it is important: the challenges of bacterial resistance
- 1 December 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (12) , 1143-1151
Abstract
Afterthe introduction of antibiotics in the mid-20th century, clinicians soon witnessed clinical failures secondary to bacterial resistance. Despite scientists’ efforts to synthesize more potent antibiotics during the last five decades, bacterial resistance continues to evolve, in large part because of the overuse and misuse of antibiotics. The treatment of several pathogens, including methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae and vancomycin-resistant enterococci, is problematic. New solutions are needed to preserve the activity of our current antibiotic armamentarium, to lower the overall risk of bacterial resistance and to successfully treat patients with resistant bacterial infections. Options include: development of new antibiotics to treat resistant organisms; vaccination to prevent infections; and improved use of antibiotics. Because bacteria will eventually develop means to avoid being killed by antibiotics, judicious use of antibiotics by all clinicians is imperative. Appropriate antibiotic use involves selection of a “targeted spectrum” antibiotic, as well as an appropriate dose and duration.Keywords
This publication has 53 references indexed in Scilit:
- Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in childrenThe Pediatric Infectious Disease Journal, 2002
- Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in childrenThe Pediatric Infectious Disease Journal, 2002
- Clinical Practice Guideline: Management of SinusitisPediatrics, 2001
- Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas childrenThe Pediatric Infectious Disease Journal, 2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- The Changing Epidemiology of Staphylococcus aureus?Emerging Infectious Diseases, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working GroupThe Pediatric Infectious Disease Journal, 1999
- Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children With No Identified Predisposing RiskJAMA, 1998
- The Crisis in Antibiotic ResistanceScience, 1992